Concepedia

Author

Jean‐Paul Vernant

Sorbonne Université

Also Known As

J P Vernant, JEAN-PAUL VERNANT, Jean-Paul Vernant, Jean-paul VERNANT, Jean-paul Vernant, Jean‐Paul Vernant, Jean–Paul Vernant

139

Publications

8.1K

Citations

40

H-Index

71

Concepts

All Affiliations

Sorbonne UniversitéPitié-Salpêtrière HospitalInsermAssistance Publique – Hôpitaux de ParisHôpital Necker-Enfants Malades
JV

About

Jean‐Paul Vernant is an author at Sorbonne Université specializing in medicine, hematology, and transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

18

1.3K

2

Health Sciences

7

7

429

3

Blood Transplantation

6

6

498

4

Language Studies

1

1

40

5

Allergy

1

1

13

Jean‐Paul Vernant

×

66

Publications

7.9K

Citations

39

H-Index

YearCitations

Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study

Françoise Huguet, Thibaut Leguay, Emmanuel Raffoux,

Journal of Clinical Oncology

2009

556

Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

Françoise Bernaudin, Gèrard Socié, Mathieu Kuentz,

Blood

2007

494

Bone Marrow Mesenchymal Stem Cells Suppress Lymphocyte Proliferation In Vitro but Fail to Prevent Graft-versus-Host Disease in Mice

Muriel Sudres, Françoise Norol, Aurélie Trenado,

The Journal of Immunology

2006

420

Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience

Paul Coppo, Michaël Schwarzinger, M. Buffet,

PLoS ONE

2010

407

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

Enric Carreras, Hartmut Bertz, William Arcese,

PubMed

1998

344

Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study

Adrienne de Labarthe, Philippe Rousselot, Françoise Huguet‐Rigal,

Blood

2006

343

Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia

Kheïra Beldjord, Sylvie Chevret, Vahid Asnafi,

Blood

2014

326

Prognostic value of anti-ADAMTS13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS13 activity

Silvia Ferrari, Friedrich Scheiflinger, Manfred Rieger,

Blood

2006

292

Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

Steven Le Gouill, Nöel Milpied, Agnès Buzyn,

Journal of Clinical Oncology

2008

291

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

Antoine Froissart, M. Buffet, Agnès Veyradier,

Critical Care Medicine

2011

286

Page 1